Total raised
$10.6M
Last: Seed 2016-08
Stage
Seed
Founded
2016
Headcount
15
HQ
Haifa
Sector
Health Tech & Life Sciences
About
Clinical-stage company offers a disruptive outpatient treatment solution addressing the top global healthcare cost driver: recurring admissions of congested Chronic Heart Failure patients.
Our implanted, connected device removes excess fluid and salt and clears them to the patient’s bladder, providing continuous decongestion: personalized precise treatment with no patient involvement, out-of-hospital.
Clinical trials are underway with strong results from an initial series of patients.
Our target US market is 1.2M+ annual hospitalizations which generate $30B+ of hospital losses and payor costs, most of which are avoidable with our technology. ROW market is larger.
Funding history · 1 round · $10.6M total
2016-08
Seed
$3.1M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsDigital HealthcarePatient Remote Monitoring
Technologies
SensingMaterials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
heart-failurecardiologymedical-productsrespiratorydoctorssurgerysurgeonsclinicshealthcare-providershospitalshome-careminimally-invasivedigital-healthcareremote-monitoringtreatments